About this Event
June 4–5, 2026 | NYU Biolabs, Long Island City
Longevity science is at an inflection point. Foundation models are learning the language of biology, aging clocks are quantifying human health with new precision, and a generation of therapeutics and clinical platforms is emerging to act on those signals.
The inaugural theme of the Summit, Signal to Intervention, explores how AI is compressing the distance between discovery and real-world impact.
As a flagship event of Longevity Global NYC, the AI x Longevity Summit convenes the researchers, clinicians, founders, and engineers building the next generation of longevity infrastructure. Hosted at NYU Biolabs in the heart of the city's biotech corridor, the Summit is where technical depth meets translational ambition.
Featured Speakers Include:
Leroy Hood (Institute for Systems Biology), Nir Barzilai (Academy for Health & Lifespan Research), Celine Halioua (Loyal), Ahmad Humayun (Google DeepMind), James Peyer (Cambrian Bio), Daniel Belsky (Columbia), Daniyal Hussain (GSK), Michael Ringel (Life Biosciences), Christin Glorioso (NeuroAge Therapeutics), and more.
Find this year's agenda, speaker lineup, and pitch competition information HERE.
What We'll Cover
Day 1: Signal — From Models to Biology Day 1 grounds AI in the realities of biological systems and examines what current capabilities mean for discovery and company building.
- Foundation models in drug discovery, target identification, and biomarker development
- Aging clocks and the science of measuring human health at new resolution
- The role of data quality, experimental design, and infrastructure in producing meaningful AI outputs
- Where models are delivering real signal versus where they remain limited
- Platform strategy, data acquisition, and differentiation for AI-native bio companies
- The investment landscape across AI x Bio and how capital is being deployed
Day 2: Intervention — From Models to Patients Day 2 shifts to deployment: how AI is being put to work in clinics, care models, and regulated environments, and what it takes to scale.
- AI in longevity clinics and preventative care
- Continuous monitoring, digital health, and real-world data integration
- Clinical decision support and personalized intervention strategies
- Regulatory and policy considerations at the intersection of AI and healthcare
- What it takes to move from model to deployment across real patient populations
Day 2 also features the live pitch competition finals for Seed and Series A companies building at the intersection of AI and longevity. Winners receive lab bench and desk space at BioLabs @ NYU Langone, and finalists pitch directly to investors, clinicians, and pharma BD teams in the room.
Who This Is For
The Summit is designed for people actively building and deploying at this intersection:
- Scientists applying AI to aging biology and disease
- Founders building AI-driven therapeutics, platforms, and diagnostics
- Investors focused on AI x Bio and digital health
- Clinicians and operators integrating AI into care models
- Pharma and BD teams evaluating new technologies
- Engineers and data scientists working on real biological and clinical systems
The format is intentionally curated to prioritize substantive exchange over scale, the kind of room where conversations go deeper and the connections actually move work forward. Full speaker lineup →
This event is part of #NYTechWeek, a week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at .
Event Venue & Nearby Stays
Innolabs, 45-18 Court Square West, Queens, United States
USD 0.00 to USD 1602.45
